Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection

This study has been completed.
Sponsor:
Collaborator:
Astellas Pharma GmbH
Information provided by (Responsible Party):
Dr. Claudia Bösmüller, Medical University Innsbruck
ClinicalTrials.gov Identifier:
NCT00147381
First received: September 6, 2005
Last updated: June 18, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
No publications provided by Medical University Innsbruck

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):